Family · Pharmaceutical analytical standards
Enadoline
A highly selective kappa opioid receptor agonist of the arylacetamide family, first described in 1990. It was studied as an analgesic and for possible use in patients with head injury or stroke, but it was never approved. This family brings together the active ingredient and labelled standards.
Did you know?In 1990 it was presented as the most potent kappa-selective analgesic ever reported up to that time.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
